Prognostic role of genetic biomarkers in clinical progression of prostate cancer

The aim of this study was to analyze the use of 12 single-nucleotide polymorphisms in genes ELAC2, RNASEL and MSR1 as biomarkers for prostate cancer (PCa) detection and progression, as well as perform a genetic classification of high-risk patients. A cohort of 451 men (235 patients and 216 controls)...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez-Cubero, Maria Jesus, Martinez-Gonzalez, Luis Javier, Saiz, Maria, Carmona-Saez, Pedro, Alvarez, Juan Carlos, Pascual-Geler, Manrique, Lorente, Jose Antonio, Cozar, Jose Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558485/
https://www.ncbi.nlm.nih.gov/pubmed/26251261
http://dx.doi.org/10.1038/emm.2015.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558485/
https://www.ncbi.nlm.nih.gov/pubmed/26251261
http://dx.doi.org/10.1038/emm.2015.43

Ejemplares similares